Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 10:00 PM ET


Company Overview of Power 3 Medical Products Inc.

Company Overview

Power3 Medical Products, Inc., a bio-technology company, focuses on the development of diagnostic tests in the fields of cancer, and neurodegenerative, and neuromuscular diseases in the United States. The company develops a portfolio of products, including BC-SeraPro, a blood serum test for the early detection of breast cancer; and NuroPro, a blood serum test for the detection of neurodegenerative diseases, such as amytrophic lateral sclerosis, Alzheimer’s, and Parkinson’s diseases. Its products are designed to analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient...

26022 Budde Road

The Woodlands, TX 77380

United States

Founded in 1992

1 Employees





Key Executives for Power 3 Medical Products Inc.

Chief Executive Officer, Interim Chief Financial Officer, Chief Accounting Officer and Director
Age: 79
Interim Chairman, President, Chief Scientific Officer, Director of Proteomics, Secretary and Member of Scientific Advisory Board
Age: 69
Director of Laboratory Operations
Age: 58
Compensation as of Fiscal Year 2015.

Power 3 Medical Products Inc. Key Developments

SEC Revokes Registration Of Registered Securities Of Power 3 Medical Products

An Administrative Law Judge has issued an Initial Decision of Default as to Power 3 Medical Products Inc. The Initial Decision found that the company was issuer of securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (Exchange Act), and the company failed to comply with Section 13(a) of the Exchange Act and Exchange Act Rules 13a-1 and/or 13a-13 by not filing required periodic reports with the Securities and Exchange Commission (SEC). The Initial Decision finds these allegations to be true and revokes the registration of each class of the company’s registered securities, pursuant to Section 12(j) of the Securities Exchange Act of 1934.

SEC Orders Hearings On Registration Suspension Or Revocation Against Power 3 Medical Products Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Power 3 Medical Products Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Similar Private Companies By Industry

Company Name Region
BioCure, Inc. United States
HairDX, LLC United States
Mpex Pharmaceuticals, Inc. United States
Onyx Pharmaceuticals, Inc. United States
Fibrocell Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Power 3 Medical Products Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at